PPD Awards

Company Accolades

• PPD was named the best contract research organization at the 2011 Scrip Awards. PPD also was honored for deploying the best technological development in clinical trials for its technology solution for managing Risk Evaluation and Mitigation Strategy (REMS) programs mandated by the U.S. Food and Drug Administration. Scrips judges called PPD “a great organization – open for new approaches, even more for driving new technologies.”  

• InformationWeek magazine named PPD to the 2011 InformationWeek 500, an annual list of the most innovative users of business technology in the United States. The award recognizes PPD’s leadership in technology investments, strategies and practices that contribute to effective drug discovery and development programs. PPD was recognized for PPD^® PatientView, an innovative online portal linking clinical trial participants with biopharmaceutical companies, physicians and health care resources to enhance patient connectivity and improve patient retention in clinical trials. In PPD’s second year being named to the list of the 500 most innovative U.S. business technology leaders, the company cracked the top 100 for the first time, moving up from the top 200 in 2010.

• Dr. Henrietta Ukwu, PPD’s senior vice president for global regulatory affairs, was named to the 2011 PharmaVOICE 100 list of the most inspiring people in the life sciences industry. The honor from PharmaVOICE magazine recognizes Dr. Ukwu’s contributions in providing innovative leadership in the area of regulatory affairs in the endeavor of delivering life-changing medicines for people in need. An internist and infectious disease physician, Dr. Ukwu has extensive global regulatory experience across many biopharmaceutical therapeutic platforms and geographic regions.

• PPD and ProtonMedia won a Microsoft 2011 Life Sciences Innovation Award for the deployment of PPD^® 3D, a virtual collaboration technology designed to improve the cost-effectiveness, speed and quality of clinical trial training. PPD collaborated with ProtonMedia to develop PPD 3D by integrating ProtonMedia's ProtoSphere, a virtual collaboration environment, with PPD^® Adaptive Solutions, an innovative suite of data, technology and performance solutions. The award was announced at the Drug Information Association's 47th annual meeting.

• PPD earned the number one spot among contract research organizations in the 2011 CenterWatch global site survey, with 84.3 percent of participants rating PPD's overall relationship quality as "excellent" or "good." According to The CenterWatch Monthly, PPD earned the number one spot by focusing on the needs of sites, which include supplying technology and support, providing clear protocols and timelines, and concentrating on strong training programs for clinical research associates.

• Randy Anderson, PPD's vice president of global product development (diabetes), was named to the 2010 PharmaVOICE 100 list of the most inspiring people in the life sciences industry. The honor recognizes Anderson's contributions in advancing treatments for diabetes and its complications.

• PPD was recognized for Leadership in Community Service by the 2010 Communitas Awards. The international award highlights PPD’s corporate and employee philanthropy programs aimed at supporting organizations in its local communities. The Communitas Awards honor exceptional businesses that unselfishly give their resources and are changing how they do business to benefit their communities.

• PPD won multiple awards at the PharmaTimes Clinical Researcher of the Year 2010 competition, including the gold award in the clinical trial administrator category. PPD earned silver recognition for clinical project manager, clinical research team and clinical company of the year. Sponsored by PharmaTimes, The Clinical Researcher of the Year competition celebrates the ability of top clinical research professionals and is based on adherence to ICH-GCP guidelines. Since its launch, the awards program has grown to include clinical researchers from all over the world.

• PPD received the 2010 Site Solutions Summit Eagle Award, highlighting the company as the most desirable contract research organization (CRO) with which to partner in an independent study of more than 300 experienced investigative sites. The award is based on the company's high level of professionalism, collaborative approach to relationships, ongoing support during clinical studies, payment terms and performance working with partner sites.

• PPD was named to the 2010 InformationWeek 500, an annual list of the nation’s most innovative users of business technology. The award recognizes the company’s strong information technology strategies, practices and investments and important areas for ensuring successful clinical research and development programs.

• PPD was rated one of Europe’s top contract research organizations (CRO) in the 2010 CenterWatch European Site Survey. The company earned a number two ranking among CROs with 78.4 percent of participants rating PPD’s overall relationship quality as "excellent" or "good." PPD scored among the top three in 26 of the 29 survey attributes and received the highest marks of any CRO for being organized and prepared, an attribute considered important for clinical trial study success. Almost 1,000 respondents from 30 countries completed the survey.

• PPD was named Best Contract Research Organization (CRO) in Asia at the World Vaccine Congress’ inaugural 2010 Vaccine Industry Excellence (ViE) Asia Awards. The award recognizes PPD’s quality of services provided in Asia and its long-standing client partnerships in the vaccine industry.

• PPD earned CEO Cancer Gold Standard™ accreditation from the CEO Roundtable on Cancer. The accreditation recognizes PPD’s commitment to creating and implementing programs aimed at educating employees on reducing their cancer risks by discouraging tobacco use, encouraging physical activity and teaching healthy diet and nutrition.

• PPD achieved national Gold Well Workplace designation by the Wellness Councils of America (WELCOA), becoming one of only two North Carolina companies honored in 2009 for its commitment to protecting and enhancing the health and well-being of its employees. Well Workplace designation is a rigorous process, which measures companies against seven health-focused benchmarks, including CEO support, creating cohesive wellness teams, data collection to drive health efforts, crafting an operating plan, choosing appropriate interventions, creating a supportive environment and consistently evaluating outcomes.

• PPD was recognized as one of the best employers in North Carolina for 2009 through a program of the North Carolina Chamber. PPD ranked seventh among all companies and was the only CRO to receive the award. The award honors the best places of employment in North Carolina, recognizing companies that benefit the state's economy and work force.

• PPD was a finalist in the best contract research organization category at the 2009 Scrip Awards. The competition is organized by Scrip World Pharmaceutical News.

• Forbes, a leading U.S. business publication, selected PPD for a second time as one of the 400 best big companies in America for 2008. PPD was also named the best-managed company in the health care equipment and services category for the second time. PPD’s first ranking on the 400 list was in 2007 after reaching $1 billion in revenues. In 2005, Forbes listed PPD as one of the best mid-cap stocks, and the company was also included as one of the 200 best small companies in the United States in 2001 and 2002.

• The Wall Street Journal ranked PPD 11^th best in stock performance for the year 2000.